REN and type 2 diabetes mellitus: We recommend using renin–angiotensin system inhibitors (RASi) (angiotensin receptor blockers—ARB or angiotensin-converting enzyme inhibitors—ACEI) as first-line antihypertensive therapy in hypertensive patients with CKD and T2D [1B].